For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss.

There is a new wave of weight-loss therapies in development that aim to be better than the existing GLP-1s.

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were ...

Wegovy is a medication typically prescribed for weight loss and cardiovascular risk reduction individuals with overweight or ...

Inclusion of weight loss drugs on insurer formularies is a meaningful step towards expanding access. But having a product ...

The United Arab Emirates becomes the second country to offer the pill after the drugmaker launched it in the U.S. in early ...

Here's what to know about weight loss drugs such as Wegovy and Zepbound. CR helps you decide whether semaglutide or ...

A DAILY weight-loss pill could be approved in Britain within days, it has been reported. A pill version of the weight loss ...

Eli Lilly just released impressive study results for retatrutide, an investigational weight loss drug that targets three ...

As the UAE becomes only the second country to approve the medication, experts explain why sustainable weight loss involves ...

Pfizer presented data ​on Saturday that showed a monthly dose of an experimental obesity drug it acquired through ‌its ...

Weight loss medications, including popular drugs like Ozempic and Wegovy, could significantly reduce the need for knee ...